Bio-techne – AmplideX Fragile X Dx & Carrier Screen Kit
Requiring only 20ng of DNA from whole blood, the assay provides results within one day.
Requiring only 20ng of DNA from whole blood, the assay provides results within one day.
Showing all 5 results
-
-
Bio-techne – AmplideX® DM1 Dx Kit
The AmplideX DM1 Dx Kit aims to revolutionize the diagnosis of DM1.
The AmplideX DM1 Dx Kit aims to revolutionize the diagnosis of DM1.
-
Bio-techne – AmplideX® PCR/CE C9orf72 Kit
The Ampli…
The AmplideX PCR/CE C9orf72 Kit* is a research product for the detection of GGGGCC repeats in the C9orf72 gene. These reagents provide a single-tube PCR approach based on a Repeat-Primed PCR (RP-PCR) design to profile repeat sequences in the C9orf72 gene.
-
Bio-techne – AmplideX® PCR/CE SMN1/2 Plus Kit
The AmplideX® SMN1/2 Plus Kit is an in vitro nucleic acid amplification kit intended to aid in the screening of carriers for and diagnosis of spinal muscular atrophy (SMA). The kit is designed for PCR with extracted genomic DNA from hu…
The AmplideX® SMN1/2 Plus Kit is an in vitro nucleic acid amplification kit intended to aid in the screening of carriers for and diagnosis of spinal muscular atrophy (SMA). The kit is designed for PCR with extracted genomic DNA from human whole blood performed on standard laboratory-validated thermal cyclers, followed by resolution on a general laboratory-validated genetic analyzer or capillary electrophoresis (CE) platform.
-
Bio-techne – QuantideX® qPCR BCR-ABL IS Kit
Confidently deliver results with the first C-certified IVDR chronic myeloid leukaemia (CML) monitoring assay with BCR ABL Major breakpoints (e13a2, e14a2). With direct reporting on the International Scale (IS) and deep clinical sensitivity of 0…
Confidently deliver results with the first C-certified IVDR chronic myeloid leukaemia (CML) monitoring assay with BCR ABL Major breakpoints (e13a2, e14a2). With direct reporting on the International Scale (IS) and deep clinical sensitivity of 0.002% (MR 4.7), laboratories can assess the deepest molecular response with unprecedented ease and deliver the results physicians and patients rely on. The QuantideX multiplex assay design and included analysis software render reporting CML monitoring results both accurate and quick, with results in ~4 hours.
© DKSH Market Expansion Services Philippines Inc. All Rights Reserved.